Whitepaper: Making APAC the Oncology Clinical Trial Destination

A new whitepaper from Premier Research makes the case that the Asia-Pacific (APAC) Region is the hot spot for oncology clinical trials. Currently, APAC stands as the region with the most ongoing oncology trials worldwide, with the number of active trials growing 138% over the last 10 years. In the whitepaper, the authors break down what factors are driving this growth and why clinical research organizations (CROs) should consider hosting their trials in the region. Chief among these reasons is the massive potential patient pool.

According to Premier Research, “The APAC region is densely populated and includes the two most populous countries – China and India. APAC accounts for 60 percent of the global population, with an urban population of over 2.3 billion people.2 Among this population are many treatment-naïve patients who may be eligible to enroll in clinical trials. Moreover, with globalization, there has been rapid growth in the middle class, a population segment that is often responsible for paying for their own healthcare and may be more open to participating in clinical trials for access to treatment.”

To download the free whitepaper, click here.

(Source: Premier Research, August 25^th, 2022)